As InnoSer transitions from the startup to scale up phase in its journey, it is also taking a number of steps to ascertain its quality management ambitions. Having dedicated personnel, expanding our current list of certifications, organizing formal audits and...
One of the greatest challenges in drug development is ensuring that the safety and efficacy results from early stages (i.e. from tests on cultured cells or animal models) translate well to administrating the drugs to humans. The gap between the results from these...
Press release | Leiden, 25 January 2021 InnoSer and Neurix form a partnership to offer neural organoids for oncology drug development applications Commercial availability of the in vitro glioblastoma Minibrain organoid platform paves the way for personalized medicine...
To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...